Rettenmaier MA - Search Results

1

Use of a murine model for comparison of intravenous and intraperitoneal cisplatin in the treatment of microscopic ovarian cancer.

Mannel RS, Stratton JA, Rettenmaier MA, Liao SY, DiSaia PJ. Mannel RS, et al. Among authors: rettenmaier ma. Gynecol Oncol. 1988 Sep;31(1):50-5. doi: 10.1016/0090-8258(88)90268-5. Gynecol Oncol. 1988. PMID: 3410355

2

Current analysis of the survival implications for minimally invasive surgery in the treatment of early-stage cervix cancer.

Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. Micha JP, et al. Among authors: rettenmaier ma. J Robot Surg. 2024 Feb 17;18(1):80. doi: 10.1007/s11701-024-01832-x. J Robot Surg. 2024. PMID: 38366169 Review.

3

Reply to the letter to the editor: a response to Tran and Egilman.

Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. Micha JP, et al. Among authors: rettenmaier ma. Arch Gynecol Obstet. 2024 Feb;309(2):727-728. doi: 10.1007/s00404-023-07013-9. Epub 2023 Apr 6. Arch Gynecol Obstet. 2024. PMID: 37022347 No abstract available.

4

Whole-abdominal radiotherapy for patients with minimal residual epithelial ovarian cancer.

Kucera PR, Berman ML, Treadwell P, Sheets EE, Micha JP, Rettenmaier MA, Colman M, DiSaia PJ. Kucera PR, et al. Among authors: rettenmaier ma. Gynecol Oncol. 1990 Mar;36(3):338-42. doi: 10.1016/0090-8258(90)90138-b. Gynecol Oncol. 1990. PMID: 2318442

5

Treatment of advanced and recurrent endometrial carcinoma: correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay.

Stratton JA, Mannel RS, Rettenmaier MA, Berman ML, DiSaia PJ. Stratton JA, et al. Among authors: rettenmaier ma. Gynecol Oncol. 1989 Jan;32(1):55-9. doi: 10.1016/0090-8258(89)90850-0. Gynecol Oncol. 1989. PMID: 2535831

6

Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage 1B cervical cancer.

Rettenmaier MA, Casanova DM, Micha JP, Moran MF, Ramsanghani NS, Syed NA, Puthawala A, DiSaia PJ. Rettenmaier MA, et al. Cancer. 1989 Jun 1;63(11):2220-3. doi: 10.1002/1097-0142(19890601)63:11<2220::aid-cncr2820631127>3.0.co;2-m. Cancer. 1989. PMID: 2720571

7

Intraperitoneal cisplatin: comparison of antitumor activity and toxicity as a function of solvent saline concentration.

Mannel RS, Stratton JA, Moran G, Rettenmaier MA, Liao SY, DiSaia PJ. Mannel RS, et al. Among authors: rettenmaier ma. Gynecol Oncol. 1989 Jul;34(1):50-3. doi: 10.1016/0090-8258(89)90105-4. Gynecol Oncol. 1989. PMID: 2737526

8

Ovarian epithelial tumors of low malignant potential.

Chien RT, Rettenmaier MA, Micha JP, DiSaia PJ. Chien RT, et al. Among authors: rettenmaier ma. Surg Gynecol Obstet. 1989 Aug;169(2):143-6. Surg Gynecol Obstet. 1989. PMID: 2756462

9

Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.

Stratton JA, Rettenmaier MA, Phillips HB, Herabutya S, DiSaia PJ. Stratton JA, et al. Among authors: rettenmaier ma. Obstet Gynecol. 1988 Jan;71(1):20-6. Obstet Gynecol. 1988. PMID: 2827081

10

Treatment of advanced and recurrent squamous carcinoma of the uterine cervix with constant intraarterial infusion of cisplatin.

Rettenmaier MA, Moran MF, Ramsinghani NF, Colman M, Syed NA, Puthawala A, Jansen FW, DiSaia PJ. Rettenmaier MA, et al. Cancer. 1988 Apr 1;61(7):1301-3. doi: 10.1002/1097-0142(19880401)61:7<1301::aid-cncr2820610704>3.0.co;2-u. Cancer. 1988. PMID: 3345485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters